← Rhythm Pharmaceuticals

What podcasts say about Rhythm Pharmaceuticals

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Rhythm Pharmaceuticals

5 statements · 5 positive

  1. Rhythm Pharmaceuticals treats a rare genetic form of obesity.

    “they treat a very rare form, a genetic form of obesity”

    Listen at 22:01

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus
  2. Rhythm Pharmaceuticals’ drug received approval for an additional indication.

    “The drug just got an additional indication approved”

    Listen at 22:35

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus
  3. Rhythm Pharmaceuticals has strong revenue growth and fund sponsorship.

    “Good revenue growth, good fund sponsorship.”

    Listen at 24:16

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus
  4. Rhythm Pharmaceuticals is an institutionally supported, high-quality biotech.

    “this one, $119 stock, so I would definitely call it an institutional exceptional quality biotech”

    Listen at 24:28

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus
  5. Rhythm Pharmaceuticals is worth watching based on its technical setup.

    “good name to watch and like the technicals here quite a bit”

    Listen at 24:40

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.